CHLOROQUINE PHOSPHATE
Chloroquine Phosphate Tablets, USP
Approved
Approval ID
ff199f31-bfda-45f8-adbd-4662f7054f1c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jul 14, 2023
Manufacturers
FDA
Chartwell RX, LLC
DUNS: 079394054
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
chloroquine phosphate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code62135-717
Application NumberANDA214756
Product Classification
M
Marketing Category
C73584
G
Generic Name
chloroquine phosphate
Product Specifications
Route of AdministrationORAL
Effective DateJuly 14, 2023
FDA Product Classification
INGREDIENTS (10)
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE AInactive
Code: H8AV0SQX4D
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CHLOROQUINE PHOSPHATEActive
Quantity: 500 mg in 1 1
Code: 6E17K3343P
Classification: ACTIB